Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors-Reference-Cited by-同舟云学术

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Published:2024-05 Issue: Volume:225 Page:105874
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Khatua Kaustav^ORCID,Alugubelli Yugendar R.,Yang Kai S.^ORCID,Vulupala Veerabhadra R.,Blankenship Lauren R.,Coleman Demonta,Atla Sandeep,Chaki Sankar P.^ORCID,Geng Zhi Zachary,Ma Xinyu R.,Xiao Jing,Chen Peng-Hsun,Cho Chia-Chuan D.,Sharma Shivangi,Vatansever Erol C.,Ma Yuying,Yu Ge,Neuman Benjamin W.^ORCID,Xu Shiqing^ORCID,Liu Wenshe Ray^ORCID

Funder

NIH

Welch Foundation

Publisher

Elsevier BV

Reference62 articles.

1. A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals;Alugubelli;Eur. J. Med. Chem.,2022

2. A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomes;Attwa;RSC Adv.,2022

3. Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors;Bai;RSC Med. Chem.,2021

4. Peptidomimetic alpha-acyloxymethylketone warheads with six-membered lactam P1 glutamine mimic: SARS-CoV-2 3CL protease inhibition, coronavirus antiviral activity, and in vitro biological stability;Bai;J. Med. Chem.,2022

5. Advances in covalent drug discovery;Boike;Nat. Rev. Drug Discov.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M^pro);ACS Omega;2024-08-02

2. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme;ACS Medicinal Chemistry Letters;2024-05-20